The FDA Advisory Committee vote on Novavax; new option for MMR vaccination; Dupixent approval expanded; and we take a look at the latest data on COVID-19 treatments.

Topics:

Atopic Dermatitis COVID19 COVID19 Vaccine Dermatological Disorders Immunization Infectious Disease Podcast Vaccines Viral Infections